Display Settings:

Items per page

Results: 6

1.
Figure 6

Figure 6. From: A novel leukocyte adhesion deficiency caused by expressed but nonfunctional ?2 integrins Mac-1 and LFA-1.

LFA-1 and Mac-1 expression profiles of K562 transfectants. Wild-type CD18 cDNA or CD18 cDNA carrying the S138P or G273R mutations were transfected into K562 together with CD11a cDNA (top panels) or CD11b cDNA (bottom panels). Expression of LFA-1 and Mac-1 was detected with the MAB 1B4 (solid lines). Background fluorescence was observed with MAB OX34 (dotted lines).

Nancy Hogg, et al. J Clin Invest. 1999 January 1;103(1):97-106.
2.
Figure 5

Figure 5. From: A novel leukocyte adhesion deficiency caused by expressed but nonfunctional ?2 integrins Mac-1 and LFA-1.

Expression patterns of β2- and β1-integrin activation reporter epitopes on T cells detected by flow cytometry after exposure to 0.5 mM Mn2+ (black) or without Mn2+ (white) at 37°C for 25 min. Control, but not patient's, T cells express β2 activation reporter epitope detected by MAB 24 (top panels). Conversely, the patient's T cells and control T cells express equivalent levels of the β1 activation reporter epitope detected with MAB HUTS 21 (bottom panels).

Nancy Hogg, et al. J Clin Invest. 1999 January 1;103(1):97-106.
3.
Figure 2

Figure 2. From: A novel leukocyte adhesion deficiency caused by expressed but nonfunctional ?2 integrins Mac-1 and LFA-1.

The ability of patient (black bars) and control (dotted bars) T-cell LFA-1 to adhere to immobilized ICAM-1 after activating stimuli (see Methods). Several treatments were used that trigger LFA-1–mediated adhesion by intracellular signaling (PDBu, cross-linking the T-cell receptor with CD3 MAB UCHT1, Ca2+ mobilizer thapsigargin) or by acting extracellularly (Mg2+/EGTA, Mn2+, or β2-activating MABs KIM 127 and KIM 185). CD11a MAB 38 inhibited binding of control T cells under all conditions (white bars). ICAM, intercellular adhesion molecule; PDBu, phorbol-12,13 dibutyrate.

Nancy Hogg, et al. J Clin Invest. 1999 January 1;103(1):97-106.
4.
Figure 3

Figure 3. From: A novel leukocyte adhesion deficiency caused by expressed but nonfunctional ?2 integrins Mac-1 and LFA-1.

The distinctive recognition by patient T-cell LFA-1 of ligands ICAM-1, ICAM-2, and ICAM-3 after various integrin-activating protocols. (a) Ability of patient T cells to bind to immobilized ICAM-1, ICAM-2, and ICAM-3 either as untreated cells (white bars) or after treatment with PDBu (dotted bars), Ca2+ mobilizer thapsigargin (gray bars), and Mg2+/EGTA (black bars). Mg2+/EGTA is seen to induce patient T cells to bind to ICAM-2 and ICAM-3 but not to ICAM-1. (b) The binding of patient T cells (black bars) and control T cells (dotted bars) to ICAM-2 after treatment with 0.5 mM Mn2+ is prevented by chelation of divalent cations with EDTA and by CD11a function blocking MAB DF1524. (c) The binding of patient T cells (black bars) and control T cells (dotted bars) to ICAM-3 after 0.5 mM Mn2+ is prevented by chelation of divalent cations with EDTA and by CD18 function blocking MAB 60.3.

Nancy Hogg, et al. J Clin Invest. 1999 January 1;103(1):97-106.
5.
Figure 4

Figure 4. From: A novel leukocyte adhesion deficiency caused by expressed but nonfunctional ?2 integrins Mac-1 and LFA-1.

The ability of patient T cells and control T cells to adhere to immobilized fibronectin via β1 integrins. (a) Control (dotted bars) and patient (black bars) T cells were untreated (RPMI), or treated with stimuli (PDBu, thapsigargin), by the β1-activating MAB TS2/16 or by ablation of integrin-mediated adhesion with 1 mM EDTA. (b) The increased adhesion of control and patient T cells to fibronectin caused by divalent cation treatment with 0.5 mM Mn2+ could be blocked by a combination of VLA-4 (α4β1)– and VLA-5 (α5β1)–specific MABs, HP1/2 and SAM-1, respectively. RPMI, Roswell Park Memorial Institute medium.

Nancy Hogg, et al. J Clin Invest. 1999 January 1;103(1):97-106.
6.
Figure 1

Figure 1. From: A novel leukocyte adhesion deficiency caused by expressed but nonfunctional ?2 integrins Mac-1 and LFA-1.

Comparison of patient and control neutrophil β2 integrins. (a) Expression of cell membrane levels of Mac-1 (CD11b/CD18) and LFA-1 (CD11a/CD18). (b) Assay of neutrophil Mac-1 function: Ability of control (white bars) and patient (black bars) neutrophils to bind to immobilized ligand fibrinogen with and without exposure to 0.1 μM FMLP. (c) Ability of patient and control neutrophils to respond to external stimuli. Control, but not patient, neutrophils are able to express the β2-integrin activation reporter epitope recognized by MAB 24, indicative of active β2 integrins (top panels). Both patient and control neutrophils can upregulate Mac-1 (bottom panels) after exposure to 0.1 μM FMLP (dotted lines, –FMLP; solid lines, +FMLP), indicating that the patient cells have a normal response to external stimuli. LFA, lymphocyte function-associated molecule; MAB, monoclonal antibody.

Nancy Hogg, et al. J Clin Invest. 1999 January 1;103(1):97-106.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk